Clinical Trial

The Bioresorbable Implants for Scaffolding Obstructions in Randomized Bifurcations (BIFSORB) Study

Study acronym: BIFSORB
Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
Coronary artery disease is often treated by implantation of permanent metallic stents.Coronary stents are required in the early healing phase after balloon dilatation but constitute a lifelong foreign body. New bioresorbable stents have been developed and are believed to improve long-term safety. The purpose of this study is to compare the safety and vessel healing after treatment of simple bifurcation lesions with the CE-marked bioresorbable stents Absorb and Desolve.
Protocol Amendment History 5 amendments
This ClinicalTrials.gov record has been amended 5 times since 2016-11-22; most recent amendment 2025-12-29.
Status change: Recruiting → Active, Not Recruiting 2017-03-14
Trial Details
NCT Number NCT02973529
Lead Sponsor Aarhus University Hospital Skejby
Conditions Coronary Artery Disease
Enrollment 120 participants
Start Date 2016-01
Primary Completion 2026-11 (estimated)
Study Completion 2028-09 (estimated)
Updated on ClinicalTrials.gov 2026-01-02